Standard News

Hide Advertisement
  • Business
  • Culture
  • News
  • Technology
  • Trending
Site logo
ADVERTISEMENT
ADVERTISEMENT

Weak Mylan board fosters EpiPen ‘debacle’: New York comptroller

By Reuters 2 min read
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington

By Ransdell Pierson

(Reuters) – New York City’s comptroller on Thursday criticized what he said are “exorbitant” price increases for Mylan NV’s <MYL.O> allergy auto-injector EpiPen and said weak board oversight of management decisions had undermined the company’s reputation and its stock price.

Advertisement

Scott Stringer said the price hikes, six times what the device cost when Mylan took it over in 2007, have prompted a public backlash and are partly responsible for a nearly 10 percent decline in Mylan’s share price in the past month alone. Stringer manages about $163 billion in pension funds for the city, including 1,059,357 shares of Mylan common stock worth about $45 million, he said.

“Mylan’s gross mismanagement of its EpiPen pricing strategy exacerbates the company’s protracted history of weak board oversight,” Stringer said in a letter to Douglas Leech, a Mylan board member who is chairman of its nominating and governance committee.

Mylan, whose tax address is in the Netherlands but with corporate headquarters in Canonsburg, Pennsylvania, has raised the U.S. price of EpiPen from less than $100 when it acquired the product to more than $600.

Amid an outcry by parents, consumer groups and U.S. politicians, the company on Monday said it will soon launch the first generic version of the device for $300, half the list price of its branded product. The EpiPen jabs a dose of the drug epinephrine into the thigh to counter dangerous allergic reactions such as to peanuts, food allergies and bee stings.

Stringer said Mylan has failed to establish independent board leadership and noted the U.S. Securities and Exchange Commission is investigating alleged land dealings between the company and its lead independent director, Rodney Piatt.

Mylan spokeswoman Nina Devlin, responding to Stringer’s criticisms, said board members, including 10 independent directors, are highly qualified and vigilant.

“The board has been actively engaged in overseeing the execution of Mylan’s growth strategy over the past decade – a strategy which has brought hundreds of products to the market,” Devlin said.

Leech and Piatt were not immediately available to comment.

Although Mylan Chief Executive Heather Bresch called the cheaper generic EpiPen an “extraordinary” commercial response, criticism has continued to rain down on the drugmaker. The U.S. House Committee on Oversight and Government Reform is investigating the company’s EpiPen pricing strategy.

(Reporting by Ransdell Pierson; Editing by Dan Grebler)

tagreuters.com2016binary_LYNXNPEC803LY-VIEWIMAGE

Advertisement - Continue reading below

‘Scary’ Lucille Ball statue replaced in her New York hometown
Entertainment
Reuters 2 min read

‘Scary’ Lucille Ball statue replaced in her New York hometown

Singer Prince died of accidental painkiller overdose: medical examiner
News
Reuters 2 min read

Singer Prince died of accidental painkiller overdose: medical examiner

Detroit teachers expected back in class after pay assurances: union
News
Reuters 2 min read

Detroit teachers expected back in class after pay assurances: union

Tesla crash raises concerns about autonomous vehicle regulation
News
Reuters 4 min read

Tesla crash raises concerns about autonomous vehicle regulation

New ‘Top Gear’ host Chris Evans steps down after just one series
Entertainment
Reuters 1 min read

New ‘Top Gear’ host Chris Evans steps down after just one series

Jack Lew urges Senate to act on Puerto Rico debt
News
Reuters 2 min read

Jack Lew urges Senate to act on Puerto Rico debt

Turning 90, Winnie-the-Pooh meets Britain’s queen in new story
Entertainment
Reuters 1 min read

Turning 90, Winnie-the-Pooh meets Britain’s queen in new story

Presidential Medal of Freedom recipient, Illinois reformer Mikva dies
News
Reuters 2 min read

Presidential Medal of Freedom recipient, Illinois reformer Mikva dies

ACLU files lawsuit over Mississippi anti-LGBT law
News
Reuters 2 min read

ACLU files lawsuit over Mississippi anti-LGBT law

Puerto Rico rescue bill advances to full House vote
News
Reuters 2 min read

Puerto Rico rescue bill advances to full House vote

load more Loading posts...

sidebar

ADVERTISEMENT
ADVERTISEMENT

sidebar-alt

  • About Us
  • Imprint
  • Contact Us
  • Terms of Service
  • Privacy Policy